(Q43834139)

27 November 2017

The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality (English)

1 reference

27 November 2017

0 references

0 references

1 reference

2

1 reference

27 November 2017

3

L Køber

1 reference

27 November 2017

N D Mygind

1

1 reference

27 November 2017

J P Goetze

4

1 reference

27 November 2017

H Nielsen

5

1 reference

27 November 2017

S Boesgaard

6

1 reference

27 November 2017

M Bay

7

1 reference

27 November 2017

J S Johansen

8

1 reference

27 November 2017

O W Nielsen

9

1 reference

27 November 2017

V Kirk

10

1 reference

27 November 2017

J Kastrup

11

1 reference

27 November 2017

language of work or name

English

0 references

publication date

31 December 2012

1 reference

Journal of Internal Medicine

27 November 2017

1 reference

27 November 2017

273

1 reference

27 November 2017

2

1 reference

27 November 2017

205-216

1 reference

YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

27 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Plasma YKL-40 levels are elevated in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Plasma YKL-40: a BMI-independent marker of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

A chitinase-like protein in the lung and circulation of patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40 identified by proteomic analysis as a biomarker of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Is the sugar always sweet in intestinal inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Heart failure and chronic obstructive pulmonary disease: An ignored combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

IL-6, but not TNF-α, increases plasma YKL-40 in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12006

21 January 2018

Identifiers

DOI

10.1111/JOIM.12006

1 reference

27 November 2017

1 reference